Lasea 80 Mg 56 Soft Capsules

Lasea (80 Mg 56 Soft Capsules)

Action and Mechanism

- Sedative. The active substances in lavender cross the blood-brain barrier and induce functional changes in the central nervous system, giving rise to the anxiolytic effect. In a pharmacological study in healthy male volunteers, a significant reduction in the binding potential of the serotonin 5-HT1A receptor was observed in brain regions involved in the regulation of anxiety.

Indications - What is Lasea indicated for?

Lasea is indicated for the treatment of transient symptoms of anxiety in adults.

Polology - How to use Lasea?

- Adults: one capsule once a day, at approximately the same time.

- Children and adolescents < 18 years: not recommended.

- Elderly: no specific dosage recommendations have been made.

Duration of treatment: should not exceed 3 months. If symptoms persist or worsen after 1 month of treatment, a doctor should be consulted.

Forgotten dose: administer the next dose at the usual time. Do not double the next dose.

Polosogy in cases of kidney failure

No specific dosage recommendations have been made.

Dosage in cases of liver failure

Contraindicated.

Rules for correct administration

Swallow the capsules without chewing, with a sufficient amount of liquid, preferably with a glass of water. It should not be taken in a lying position.

Administration with food: can be taken with or without food.

Advice to the patient

- If symptoms persist unchanged after 1 month of treatment or if they worsen, a doctor should be consulted.

Lasea Contraindications

- Hypersensitivity to lavender or any component of the medication.

- Deterioration of liver function, such as liver failure.

Precautions

- [DIALYSIS]. Not recommended due to lack of clinical data.

Precautions regarding excipients

- This medicine contains sorbitol. Patients with hereditary fructose intolerance should not take this medication.

Interactions

They have not been described. However, the association with other anxiolytic drugs, sedatives or alcohol is not recommended due to the lack of clinical data on potential interactions.

Pregnancy - Can I use Lasea during pregnancy?

Safety in animals: Animal studies do not suggest direct or indirect harmful effects in terms of reproductive toxicity.

Safety in humans: There are no adequate and well-controlled studies in humans. Its use is not recommended.

Effects on fertility: no specific studies have been performed in humans. Animal studies have shown no harmful effects on fertility.

Breastfeeding - Can I use Lasea while breastfeeding?

Safety in animals: no data available.

Safety in humans: it is unknown if it is excreted with milk, and the consequences it could have for the infant. Its administration is not recommended during breastfeeding.

Children

Safety and efficacy have not been evaluated in children and adolescents < 18 years of age, so it is recommended to avoid its use.

Advanced age

Limited data are available on safety and efficacy in patients over 65 years of age. However, no specific dosage recommendations have been established.

Effects on driving

It does not present significant effects. However, patients who complain of fatigue should not drive or use machines. No data are available for patients over 58 years of age.

Adverse reactions

Adverse reactions are described according to each frequency interval, being considered very common (>10%), common (1-10%), uncommon (0.1-1%), rare (0.01-0.1%). , very rare (<0.01%) or of unknown frequency (cannot be estimated from the available data).

- Gastrointestinal disorders: frequent aerophagia; frequency unknown other gastrointestinal complaints.

- Skin and subcutaneous tissue disorders: skin hypersensitivity reactions.

Adverse reactions related to excipients

- This medicine contains sorbitol. Daily doses greater than 10 g of sorbitol taken orally may have a slight laxative effect and lead to [DIARREA].

Overdose

Symptoms: no cases have been described.

Measures to take:

- Antidote: there is no specific antidote.

- General disposal measures: have not been established.

- Monitoring: patient monitoring does not seem necessary.

- Treatment: symptomatic.

Prospect 

Lasea Leaflet (80 Mg 56 Softgels)